Ranica, Italy

Paolo Degan

This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignees: Eli Lilly and Company, Nuova Ompi Srl Unipersonale. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Degan. Retrieved from https://idiyas.com/inventor/paolo-degan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Paolo Degan: Innovator in Wearable Technology

Introduction

Paolo Degan is a notable inventor based in Ranica, Italy. He has made significant contributions to the field of wearable technology, particularly in the development of innovative injector components. With a total of 8 patents to his name, Degan has established himself as a key figure in the industry.

Latest Patents

Among his latest patents are the Wearable Injector Component and the Wearable Injector. These inventions showcase his commitment to enhancing medical technology and improving patient care through innovative solutions.

Career Highlights

Degan has worked with prominent companies such as Eli Lilly and Company and Nuova Ompi Srl Unipersonale. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking projects in the pharmaceutical and medical device sectors.

Collaborations

Throughout his career, Paolo has collaborated with talented individuals, including Tommaso Borghi and Mattia Cattaneo. These partnerships have fostered a creative environment that has led to the development of impactful inventions.

Conclusion

Paolo Degan's work in wearable technology exemplifies the spirit of innovation. His patents and collaborations reflect a dedication to advancing medical solutions that benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…